Among these, the PTEN located at 10q23.31, has emerged as a key tumour suppressor gene implicated in prostate cancer [4] and has been shown to distinguish indolent from aggressive tumours, thereby predicting disease progression [6,7]. The gene discussed is PTEN; the disease is prostate carcinoma.